Javed Butler Selected Research

Heart Failure

10/2022	Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.
10/2022	Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Reduced.
8/2022	Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes.
6/2022	Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF.
6/2022	Longitudinal Changes in Cardiac Troponin and Risk of Heart Failure Among Black Adults.
6/2022	Patient-reported and Clinical Outcomes Among Patients Hospitalized for Heart Failure With Reduced Versus Preserved Ejection Fraction.
5/2022	Optimizing Foundational Therapies in Patients With HFrEF: How Do We Translate These Findings Into Clinical Care?
4/2022	Troponin is unrelated to outcomes in heart failure patients discharged from the emergency department.
2/2022	Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction.
1/2022	Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Javed Butler Research Topics

Disease

457	Heart Failure 10/2022 - 06/2003
32	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2017
26	Myocardial Infarction 11/2022 - 11/2002
25	Cardiomyopathies (Cardiomyopathy) 01/2022 - 12/2009
22	Atrial Fibrillation 01/2022 - 03/2009
18	Cardiovascular Diseases (Cardiovascular Disease) 09/2022 - 03/2005
17	Hypertension (High Blood Pressure) 01/2022 - 02/2004
17	Chronic Renal Insufficiency 01/2022 - 07/2014
16	Inflammation (Inflammations) 10/2019 - 07/2009
15	Diabetes Mellitus 01/2021 - 01/2004
14	Stroke (Strokes) 11/2020 - 09/2005
13	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 03/2009
12	Hyperkalemia 01/2022 - 03/2015
12	Fibrosis (Cirrhosis) 01/2022 - 09/2015
11	Hypotension (Low Blood Pressure) 01/2022 - 01/2016
10	Dyspnea (Shortness of Breath) 01/2022 - 03/2014
9	Coronary Disease (Coronary Heart Disease) 01/2022 - 04/2004
9	Neoplasms (Cancer) 01/2021 - 01/2016
8	Acute Coronary Syndrome 04/2022 - 03/2006
8	COVID-19 01/2022 - 10/2020
8	Left Ventricular Dysfunction 01/2022 - 10/2007
7	Iron Deficiencies 01/2022 - 05/2017
7	Body Weight (Weight, Body) 01/2021 - 09/2005
6	Atherosclerosis 01/2022 - 03/2009
6	Heart Diseases (Heart Disease) 01/2022 - 02/2014
6	Cardiac Arrhythmias (Arrythmia) 01/2021 - 05/2013
5	Weight Loss (Weight Reduction) 01/2021 - 07/2012
5	Renal Insufficiency (Renal Failure) 01/2021 - 02/2004
5	Ventricular Remodeling 01/2021 - 03/2013
5	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2020 - 07/2008
5	Chest Pain (Chest Pains) 10/2018 - 11/2006
4	Frailty 01/2022 - 02/2014
4	Obesity 01/2022 - 01/2005
4	Anemia 11/2021 - 05/2014
4	Hypertrophy 10/2021 - 07/2009

Drug/Important Bio-Agent (IBA)

49	empagliflozinIBA 11/2022 - 01/2017
49	Biomarkers (Surrogate Marker)IBA 10/2022 - 11/2006
47	SodiumIBA 01/2022 - 10/2007
46	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2008
40	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2022 - 02/2004
36	DiureticsIBA 01/2022 - 06/2003
28	Pharmaceutical PreparationsIBA 10/2021 - 04/2013
22	Natriuretic PeptidesIBA 01/2022 - 08/2008
21	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 06/2004
21	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 04/2012
20	pro-brain natriuretic peptide (1-76)IBA 10/2022 - 02/2012
20	CreatinineIBA 01/2022 - 01/2004
20	vericiguatIBA 01/2022 - 09/2014
18	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2017
17	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 01/2018
17	Tolvaptan FDA Link 01/2018 - 03/2012
16	SymportersIBA 01/2022 - 08/2017
15	Vasopressins (Vasopressin)IBA 01/2018 - 03/2012
14	Neprilysin (Neutral Endopeptidase)IBA 06/2022 - 01/2018
14	Sodium-Glucose Transport ProteinsIBA 02/2022 - 01/2017
14	Angiotensin Receptor AntagonistsIBA 01/2022 - 12/2012
14	Spironolactone (Aldactone)FDA LinkGeneric 01/2021 - 07/2014
12	Angiotensin Receptors (Angiotensin II Receptor)IBA 06/2022 - 03/2015
12	PotassiumIBA 01/2022 - 03/2015
9	TroponinIBA 06/2022 - 08/2008
9	Soluble Guanylyl CyclaseIBA 10/2020 - 03/2013
9	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2019 - 06/2013
9	Digoxin (Digitek)FDA LinkGeneric 09/2017 - 03/2009
7	AlbuminsIBA 10/2022 - 07/2008
7	CanagliflozinIBA 01/2022 - 01/2018
7	AngiotensinsIBA 06/2021 - 11/2009
7	C-Reactive ProteinIBA 01/2021 - 09/2006
6	Troponin T (Troponin T1)IBA 10/2022 - 12/2019
6	Hemoglobins (Hemoglobin)IBA 11/2021 - 12/2009
6	AldosteroneIBA 01/2020 - 11/2009
6	ReninIBA 01/2020 - 11/2009
6	Hydralazine (Apresoline)FDA LinkGeneric 12/2019 - 05/2011
5	Insulin (Novolin)FDA Link 10/2022 - 09/2009
5	Uric Acid (Urate)IBA 01/2022 - 12/2014
5	dapagliflozinIBA 01/2022 - 10/2019
5	ferric carboxymaltoseIBA 01/2022 - 12/2020
5	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 03/2010
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 11/2005
5	LipidsIBA 01/2022 - 05/2007
5	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 10/2018
5	IronIBA 01/2022 - 05/2017
5	Biological ProductsIBA 01/2022 - 01/2018
5	patiromerIBA 01/2022 - 10/2016
5	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 08/2011
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 09/2006
5	CytokinesIBA 01/2021 - 01/2012
5	Proteins (Proteins, Gene)FDA Link 11/2019 - 03/2005
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 03/2010
4	Troponin IIBA 06/2022 - 11/2012
4	Furosemide (Lasix)FDA LinkGeneric 11/2021 - 03/2014

Therapy/Procedure

192	Therapeutics 08/2022 - 11/2002
26	Patient Readmission 01/2022 - 10/2007
9	Length of Stay 08/2017 - 04/2006
8	Heart Transplantation (Grafting, Heart) 01/2022 - 10/2003
8	Heart-Assist Devices 01/2018 - 08/2007
5	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 01/2016
5	Drug Therapy (Chemotherapy) 01/2021 - 10/2014
5	Transplantation 01/2017 - 08/2007
4	Contraindications 01/2022 - 01/2005
4	Critical Care (Surgical Intensive Care) 10/2021 - 01/2009